History＆Awards
March
Time: 2022-03-17
Source: Viva Biotech
Share:
[Abstract]:Acquired the entire equity of SYNthesis, accelerating the expansion of global innovation and productivity of R&D in drug industries.
Media contact: vivapr@vivabiotech.com
Contact Us
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us